AstraZeneca's drug pipeline is still "under-appreciated", according to UBS which hiked its target price for the stock by 10% on Friday. The bank said it sees a number of "blockbuster opportunities" for the pharmaceutical group in the near term, as it lifted its target for the shares from 5,000p to 5
Read moreDisappointing UK economic data and nervousness ahead of a key labour-market report in the States sent London's FTSE 100 lower on Friday morning, as stocks pulled back after a surge the previous session. By around lunchtime, the Footsie was trading nearly 0.7% lower at 6,527 with weakness among super
Read more** Electronic components maker Laird top UK midcap faller, down more than 8 pct, as investors lock in profits after a strong run into an in-line trading update on Friday ** Stock had risen more than 7 pct in 3 days prior to the statement ** Co says in a brief statement its expectatio
Read moreNumis Securities has maintained its 'buy' recommendation for Laird, but highlighted a slowdown in organic growth at the electronic components supplier towards the end of the year. The company, which designs technology used in mobile devices and supplies companies such as Apple, said it would meet co
Read moreUK stocks endured a subdued start on Friday morning following a huge jump the previous session as markets paused for breath ahead of the pivotal US jobs report. The FTSE 100 was down 0.2% at 6,554 early on, with supermarket stocks pulling back after a strong rally and housebuilders hit by some negat
Read moreElectronic components supplier Laird, a key supplier for Apple's devices, announced its confidence in meeting expectations for full year results after a good fourth quarter. The FTSE 250 group, whose technologies prevent electrical interference and overheating in smartphones and other mobile devices
Read more